Orion S.A.
corporate_fare Company Profile
Orion S.A. (NYSE:OEC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for OEC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for OEC spans 10-Q, DEF 14A, 8-K, 10-K.
Recent high-impact activity:
- Orion 10-Q: Q3 Net Loss $3.1M, Adjusted EBITDA Up 16% to $66.8M
- Orion Tightens 2026 EBITDA Guidance to $190-200M After Q3 Beat on Cash Flow
- Darolutamide Cuts Metastasis or Death Risk 58% in High-Risk Prostate Cancer Trial
- Orion Lifts 2026 Sales and EBIT Outlook on Stronger Royalties
- Orion Pharma Secures Exclusive European Rights to Qilu's Pembrolizumab Biosimilar
Financial Snapshot
Short Interest & Short Volume
5.02 days to coverFINRA reported short interest of 2,182,490 shares in OEC as of the October 30, 2026 settlement, a 1.0% decrease from the prior period — about 5.0 days to cover at its recent average daily volume. On November 20, 2026, 51.3% of OEC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.